UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The discovery of TAFI

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2139-2146

2005

Volltextzugriff (PDF)

The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system

The Journal of biological chemistry, 1990-10, Vol.265 (28), p.16948-16954

1990

Volltextzugriff (PDF)

The Profibrinolytic Effect of Activated Protein C in Clots Formed From Plasma Is TAFI-Dependent

Blood, 1996-09, Vol.88 (6), p.2093-2100

1996

Volltextzugriff (PDF)

EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease

Thrombosis research, 2010-08, Vol.126 (2), p.e110-e115

2010

Volltextzugriff (PDF)

Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors

Journal of thrombosis and haemostasis, 2007-06, Vol.5 (6), p.1257-1264

2007

Volltextzugriff (PDF)

KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children

Thrombosis research, 2009-03, Vol.123 (5), p.707-709

2009

Volltextzugriff (PDF)

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

Arteriosclerosis, thrombosis, and vascular biology, 2000-12, Vol.20 (12), p.2511-2518

Bajzar, L

2000

Volltextzugriff (PDF)

Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity

Journal of thrombosis and haemostasis, 2008-05, Vol.6 (5), p.848-855

2008

Volltextzugriff (PDF)

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

The Journal of clinical investigation, 1997-05, Vol.99 (10), p.2323-2327

1997

Volltextzugriff (PDF)

Prothrombinase Components Can Accelerate Tissue Plasminogen Activator-catalyzed Plasminogen Activation

The Journal of biological chemistry, 1995-07, Vol.270 (30), p.17871-17877

1995

Volltextzugriff (PDF)

Warfarin induced coagulopathy in children: assessment of a conservative approach

Archives of disease in childhood, 2011-02, Vol.96 (2), p.164-167, Article 164

2011

Volltextzugriff (PDF)

Novel uses of insulin syringes to reduce dosing errors: A retrospective chart review of enoxaparin whole milligram dosing

Thrombosis research, 2009-04, Vol.123 (6), p.845-847

2009

Volltextzugriff (PDF)

The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation

The Journal of biological chemistry, 1993-04, Vol.268 (12), p.8608-8616

1993

Volltextzugriff (PDF)

TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex

The Journal of biological chemistry, 1996-07, Vol.271 (28), p.16603-16608

1996

Volltextzugriff (PDF)

The Intrinsic Threshold of the Fibrinolytic System Is Modulated by Basic Carboxypeptidases, but the Magnitude of the Antifibrinolytic Effect of Activated Thrombin-activable Fibrinolysis Inhibitor Is Masked by Its Instability

The Journal of biological chemistry, 2004-07, Vol.279 (27), p.27896-27904

2004

Volltextzugriff (PDF)

Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor

The Journal of biological chemistry, 1995-06, Vol.270 (24), p.14477-14484

1995

Volltextzugriff (PDF)

A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor

The Journal of biological chemistry, 1998-10, Vol.273 (42), p.27176-27181

1998

Volltextzugriff (PDF)

Channeling During Prothrombin Activation

The Journal of biological chemistry, 2001-08, Vol.276 (31), p.28686-28693

2001

Volltextzugriff (PDF)

A novel approach to arterial thrombolysis

Blood, 1999-10, Vol.94 (8), p.2735-2743

1999

Volltextzugriff (PDF)

Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A)

The Journal of biological chemistry, 1994-04, Vol.269 (15), p.11374-11380

1994

Volltextzugriff (PDF)

ID: 326 The Intrinsic Antifibrinolytic Effect of Carboxypeptidase N is Attenuated by an Inhibitory Component(s) in Plasma

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (s1), p.214-214

2006

Volltextzugriff (PDF)

Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis

Thrombosis and haemostasis, 1997, Vol.78 (1), p.386-391

1997

Volltextzugriff (PDF)

HISTORICAL SKETCH: The discovery of TAFI

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2139-2146

2005

Volltextzugriff (PDF)

Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties

The Journal of biological chemistry, 1998-01, Vol.273 (4), p.2127-2135

1998

Volltextzugriff (PDF)

Thrombin activatable fibrinolysis inhibitor: Not just an inhibitor of fibrinolysis

Critical care medicine, 2004-05, Vol.32 (5 Suppl), p.S320-S324

2004

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The discovery of TAFI

The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system

The Profibrinolytic Effect of Activated Protein C in Clots Formed From Plasma Is TAFI-Dependent

EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease

Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors

KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

Prothrombinase Components Can Accelerate Tissue Plasminogen Activator-catalyzed Plasminogen Activation

Warfarin induced coagulopathy in children: assessment of a conservative approach

Novel uses of insulin syringes to reduce dosing errors: A retrospective chart review of enoxaparin whole milligram dosing

The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation

TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex

The Intrinsic Threshold of the Fibrinolytic System Is Modulated by Basic Carboxypeptidases, but the Magnitude of the Antifibrinolytic Effect of Activated Thrombin-activable Fibrinolysis Inhibitor Is Masked by Its Instability

Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor

A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor

Channeling During Prothrombin Activation

A novel approach to arterial thrombolysis

Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A)

ID: 326 The Intrinsic Antifibrinolytic Effect of Carboxypeptidase N is Attenuated by an Inhibitory Component(s) in Plasma

Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis

HISTORICAL SKETCH: The discovery of TAFI

Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties

Thrombin activatable fibrinolysis inhibitor: Not just an inhibitor of fibrinolysis

Suchergebnisse filtern